Finance

Lists
Why is CT9 down 8,15%?
Dive Deeper
CT9:FRA
Cardiol Therapeutics Inc
1,10 €
-8,15%
(-0,098) 1D
6 қаз., 08:03:57 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for CT9...
Open
1,10 €
High
1,10 €
Low
1,10 €
Mkt. cap
229,54 млн
Avg. vol.
1,96 мың
Volume
0,00
52-wk high
1,95 €
52-wk low
0,73 €
No. of employees
18
Open
1,10 €
High
1,10 €
Low
1,10 €
Mkt. cap
229,54 млн
Avg. vol.
1,96 мың
Volume
0,00
52-wk high
1,95 €
52-wk low
0,73 €
No. of employees
18
News stories
From web sources and news partners
About Cardiol Therapeutics Inc
CEODavid Elsley
Employees18
Founded2017
HeadquartersОквил, Онтарио, Канада
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,79 млн
2,74 млн
4,95 млн
3,20 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,39 млн
5,29 млн
4,76 млн
4,74 млн
Operating expense
10,18 млн
8,03 млн
9,71 млн
7,94 млн
Total operating expenses
10,18 млн
8,03 млн
9,71 млн
7,94 млн
Operating income
-10,18 млн
-8,03 млн
-9,71 млн
-7,94 млн
Other non operating income
-
951,74 м.
-1,53 млн
1,35 млн
EBT including unusual items
-9,96 млн
-7,21 млн
-10,82 млн
-6,08 млн
EBT excluding unusual items
-9,96 млн
-7,21 млн
-10,82 млн
-6,08 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9,96 млн
-7,21 млн
-10,82 млн
-6,08 млн
Net profit margin
-
-
-
-
Earnings per share
-0,12
-0,07
-0,10
-0,05
Interest and investment income
122,26 м.
175,21 м.
200,72 м.
201,33 м.
Interest expense
-
-
-
-
Net interest expenses
122,26 м.
175,21 м.
200,72 м.
201,33 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-10,17 млн
-8,02 млн
-9,70 млн
-7,93 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары